RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jacobson Pharma Corporation Stock

Jacobson Pharma Corporation Revenue 2024

Jacobson Pharma Corporation Revenue

1.47 B HKD

Ticker

2633.HK

ISIN

KYG677291067

In 2024, Jacobson Pharma Corporation's sales reached 1.47 B HKD, a 15.79% difference from the 1.27 B HKD sales recorded in the previous year.

The Jacobson Pharma Corporation Revenue history

YEARREVENUE (undefined HKD)GROSS MARGIN (%)
20241.4742,27
20231.2742,51
20221.638,89
20211.4538,80
20201.5743,91
20191.4845,64
20181.5539,88
20171.2644,34
20161.0845,00
20150.9540,60
20140.9345,86

Jacobson Pharma Corporation Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Jacobson Pharma Corporation, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Jacobson Pharma Corporation from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Jacobson Pharma Corporation’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Jacobson Pharma Corporation. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Jacobson Pharma Corporation’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Jacobson Pharma Corporation’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Jacobson Pharma Corporation’s growth potential.

Jacobson Pharma Corporation Revenue, EBIT and net profit per share

DateJacobson Pharma Corporation RevenueJacobson Pharma Corporation EBITJacobson Pharma Corporation Net Income
20241.47 B undefined311.4 M undefined266.97 M undefined
20231.27 B undefined269.27 M undefined251.04 M undefined
20221.6 B undefined245.97 M undefined177.67 M undefined
20211.45 B undefined164.33 M undefined173.71 M undefined
20201.57 B undefined303.17 M undefined215.63 M undefined
20191.48 B undefined339.07 M undefined250.56 M undefined
20181.55 B undefined280.12 M undefined202.27 M undefined
20171.26 B undefined225.79 M undefined179.33 M undefined
20161.08 B undefined190.2 M undefined145.61 M undefined
2015947.59 M undefined137.72 M undefined101.9 M undefined
2014926.2 M undefined162.4 M undefined172.4 M undefined

Jacobson Pharma Corporation stock margins

The Jacobson Pharma Corporation margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Jacobson Pharma Corporation. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Jacobson Pharma Corporation.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Jacobson Pharma Corporation's sales revenue. A higher gross margin percentage indicates that the Jacobson Pharma Corporation retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Jacobson Pharma Corporation's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Jacobson Pharma Corporation's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Jacobson Pharma Corporation's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Jacobson Pharma Corporation. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Jacobson Pharma Corporation's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Jacobson Pharma Corporation Margin History

Jacobson Pharma Corporation Gross marginJacobson Pharma Corporation Profit marginJacobson Pharma Corporation EBIT marginJacobson Pharma Corporation Profit margin
202442.27 %21.22 %18.19 %
202342.51 %21.24 %19.8 %
202238.89 %15.42 %11.14 %
202138.8 %11.36 %12.01 %
202043.91 %19.29 %13.72 %
201945.64 %22.94 %16.95 %
201839.88 %18.09 %13.06 %
201744.34 %17.98 %14.28 %
201645 %17.55 %13.43 %
201540.6 %14.53 %10.75 %
201445.86 %17.53 %18.61 %

Jacobson Pharma Corporation Aktienanalyse

What does Jacobson Pharma Corporation do?

Jacobson Pharma Corporation ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Jacobson Pharma Corporation's Sales Figures

The sales figures of Jacobson Pharma Corporation originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Jacobson Pharma Corporation’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Jacobson Pharma Corporation's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Jacobson Pharma Corporation’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Jacobson Pharma Corporation stock

How much revenue did Jacobson Pharma Corporation generate this year?

Jacobson Pharma Corporation has achieved a revenue of 1.47 B HKD this year.

How much was the turnover of the company Jacobson Pharma Corporation compared to the previous year?

The revenue of Jacobson Pharma Corporation has increased by 15.79% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Jacobson Pharma Corporation?

The revenue of Jacobson Pharma Corporation is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Jacobson Pharma Corporation measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Jacobson Pharma Corporation so important for investors?

The revenue of Jacobson Pharma Corporation is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Jacobson Pharma Corporation pay?

Over the past 12 months, Jacobson Pharma Corporation paid a dividend of 0.03 HKD . This corresponds to a dividend yield of about 4.41 %. For the coming 12 months, Jacobson Pharma Corporation is expected to pay a dividend of 0.03 HKD.

What is the dividend yield of Jacobson Pharma Corporation?

The current dividend yield of Jacobson Pharma Corporation is 4.41 %.

When does Jacobson Pharma Corporation pay dividends?

Jacobson Pharma Corporation pays a quarterly dividend. This is distributed in the months of January, September, January, October.

How secure is the dividend of Jacobson Pharma Corporation?

Jacobson Pharma Corporation paid dividends every year for the past 8 years.

What is the dividend of Jacobson Pharma Corporation?

For the upcoming 12 months, dividends amounting to 0.03 HKD are expected. This corresponds to a dividend yield of 4.41 %.

In which sector is Jacobson Pharma Corporation located?

Jacobson Pharma Corporation is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jacobson Pharma Corporation kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jacobson Pharma Corporation from 10/4/2024 amounting to 0.03 HKD, you needed to have the stock in your portfolio before the ex-date on 9/3/2024.

When did Jacobson Pharma Corporation pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Jacobson Pharma Corporation in the year 2023?

In the year 2023, Jacobson Pharma Corporation distributed 0.073 HKD as dividends.

In which currency does Jacobson Pharma Corporation pay out the dividend?

The dividends of Jacobson Pharma Corporation are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jacobson Pharma Corporation

Our stock analysis for Jacobson Pharma Corporation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jacobson Pharma Corporation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.